Navigation Links
Nonlinear Dynamics announces more details of its global partnership with PerkinElmer

Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, today announced further details of its global OEM partnership with PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research and analytical solutions.

As detailed in a press release issued last week, PerkinElmer will distribute Nonlinear's full range of 1D, 2D and array software. However the agreement also represents the formation of an integrated partnership between the two companies, with Nonlinear now formally established as PerkinElmer's principal software partner for all proteomics applications.

Mary Lopez, Business Leader for Analytical Proteomics at PerkinElmer said, "PerkinElmer was eager to establish a single strong proteomics software and bioinformatics partner going into 2005 and beyond. In entering this collaboration with Nonlinear, we are firmly endorsing Nonlinear Dynamics as that partner. The product and corporate synergies between PerkinElmer and Nonlinear made this a natural choice to benefit our customers into the future."

She continued, "PerkinElmer is re-launching its gel imaging strategy this year with ProXPRESS, our new consumables and Nonlinear's software as the centrepieces to that strategy. Our intention is to reaffirm PerkinElmer as the first choice in gel imaging, whether it be for 1D or 2D gels, blots or any other applications."

John Spreadbury, Group Sales and Marketing Director of Nonlinear Dynamics and CEO of Nonlinear USA Inc., added, "Nonlinear has provided PerkinElmer with software for a number of years now and we are very excited by this positive assertion by PerkinElmer of Nonlinear's central role within its proteomics strategy. Together we have a number of new initiatives which we are already working on. We are confident that the extensive fruits of this relationship will continue to benefit the proteomics community for many years to come."


'"/>

Source:Nonlinear Dynamics


Page: 1

Related biology news :

1. Wiley announces publication of Databasing the Brain
2. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
3. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
4. GlycoFi announces the first production of antibodies with human glycosylation in yeast
5. NHGRI announces new sequencing targets
6. CHAVI announces international search for genes affecting HIV response
7. NHGRI announces latest sequencing targets
8. MUHC announces a transplant first in Quebec
9. St. Jude announces breakthrough in eye cancer treatment
10. NIH announces phase III clinical trial of creatine for Parkinsons disease
11. Researcher uncovers details of how cancer spreads
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... AUSTIN, Texas , Dec. 1, 2016 /PRNewswire/ ... provider, today announced BioLock , an electrocardiogram ... and health monitoring, a key IoT asset. The ... embedded into a vehicle,s steering wheel and mobile ... a simple touch. As vehicle technology ...
(Date:11/29/2016)... , Nov. 29, 2016   ... identification and object recognition technologies, today released ... for fingerprint recognition solutions that run on ... fingerprint template using less than 128KB of ... compact devices that have limited on-board resources, ...
(Date:11/22/2016)... -- According to the new market research report "Biometric System ... Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, and ... expected to grow from USD 10.74 Billion in 2015 to reach USD ... 2022. Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Ben Franklin Technology Partners of Southeastern Pennsylvania ... ("IHG"), the parent company of Independence Blue Cross; and ... announced their intentions for a $6 million funding initiative ... healthcare startups. Responding to a burgeoning economic ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA ... dose escalation and expansion clinical trial for its lead drug candidate, AC0010, at ... of the trial was to determine the safety, antitumor activity, and recommended phase ...
(Date:12/7/2016)... ... December 07, 2016 , ... Huffman Engineering, Inc. ... a Wonderware Certified System Integrator Partner. Huffman Engineering is the only Nebraska-based ... “The System Integrator Partner certification gives customers confidence that our engineers are fully ...
(Date:12/7/2016)... 7, 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a ... of immunotherapeutic products for the treatment of cancer, ... Antibody Manufacturing Development Program with Cytovance Biologics ( ... its oregovomab antibody product. Supported by recent positive ... study in ovarian cancer patients, OncoQuest has engaged ...
Breaking Biology Technology: